Cited by

• Anticholinergic agents can induce oromandibular dyskinesia.

  Shin HY, Yoon WT, Lee WY. Shin HY, et al. J Mov Disord. 2009 Oct;2(2):69-71. doi: 10.14802/jmd.09018. Epub 2009 Oct 30. J Mov Disord. 2009. PMID: 24868360 Free PMC article.
• Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.

  Chouinard G, Boisvert D, Bradwejn J. Chouinard G, et al. Can Med Assoc J. 1982 Apr 1;126(7):821-2, 827. Can Med Assoc J. 1982. PMID: 6122496 Free PMC article. No abstract available.
• Chronic benztropine and haloperidol administration induce behaviorally equivalent pharmacological hypersensitivities separately but not in combination.

  Carey RJ, De Veaugh-Geiss J. Carey RJ, et al. Psychopharmacology (Berl). 1982;76(4):341-5. doi: 10.1007/BF00449122. Psychopharmacology (Berl). 1982. PMID: 6812108
• Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonism.

  Gerlach J. Gerlach J. Psychopharmacology (Berl). 1977 Mar 16;51(3):259-63. doi: 10.1007/BF00431633. Psychopharmacology (Berl). 1977. PMID: 403541
• Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

  Rinne UK, Birket-Smith E, Dupont E, Hansen E, Hyyppä M, Marttila R, Mikkelsen B, Pakkenberg H, Presthus J. Rinne UK, et al. J Neurol. 1975 Dec 2;211(1):1-9. doi: 10.1007/BF00312459. J Neurol. 1975. PMID: 56427 Clinical Trial.